Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Conditions

Tumor Lysis Syndrome 2Lymphoma 1Leukemia 1Inflammation 1Hyperuricemia 1Hematologic Neoplasms 1Gout 1Cardiovascular Diseases 1Arthritis 1

Interventions

Omeprazole 2soybean oil, phospholipid emulsion 1salicylsalicylic acid 1ginger extract 1epigallocatechin gallate 1Vitamin D 1Sulindac 1Sodium Salicylate 1Riluzole 1Radiotherapy, Conformal 1Naproxen 1Febuxostat 1Etanercept 1Dexlansoprazole 1Colchicine 1ClinOleic 1Ascorbic Acid 1Art Therapy 1Allopurinol 1Adalimumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Inflammation × Febuxostat × Clear all
NCT02500641 2019-06-21

FORWARD

Menarini International Operations Luxembourg SA

Phase 4 Completed
196 enrolled 9 charts

Arthritis, Cardiovascular Diseases, Gout, Inflammation, Hyperuricemia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡